Damora Therapeutics Inc

Damora Therapeutics, Inc. is a biotechnology company. The Company focuses on advancing novel subcutaneous biologics to provide disease-modifying treatments for the patients living with mutant calreticulin-driven myeloproliferative neoplasms. Damora Therapeutics operates in the United States.